Sotera Health 2025 revenue rises 5.7% to $1.164 billion; net income $78 million
Sotera Health reported full-year 2025 net revenues up 5.7% to $1.164 billion and net income of $78 million, or $0.27 per diluted share, compared with $44 million, or $0.16 per diluted share, in 2024. The company also gave initial 2026 guidance for net revenues of $1.233 billion to $1.251 billion and Adjusted EBITDA of $632 million to $641 million. General Counsel Alex Dimitrief retires March 31, 2026, will serve as an advisor on ethylene oxide litigation, and Erika Ostrowski becomes Senior Vice President and General Counsel effective April 1, 2026.
Key points
- Fourth-quarter 2025 net revenues rose 4.6% to $303 million, and net income was $35 million, or $0.12 per diluted share, versus $12 million a year earlier.
- Full-year 2025 Adjusted EBITDA increased 8.2% to $594 million, and Adjusted EPS was $0.86, up $0.16 per diluted share.
- 2026 outlook: net revenues of $1.233 billion to $1.251 billion and Adjusted EPS of $0.93 to $1.01.
- Dimitrief's advisory agreement is expected to pay $22,500 per month for up to 12 months.
The filing
Written by AI on Nov 8, 2026, 1:00 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 24, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.